Brief: Parnell Pharmaceuticals restructures board
Oct 9 (Reuters) - Parnell Pharmaceuticals Holdings Ltd PARN.O : * Restructures board * Engagement of Egon Zhender to identify and assist in appointment of additional independent directors * Accepted resignation of Thomas Duley, Phyllis Gardner, and David Greenwood as directors of co * Says intends to appoint additional independent directors in the near term * Source text for Eikon ID:nGNXVEOXOa * Further company coverage PARN.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Parnell Pharmaceuticals Holdings
See all newsBrief: Parnell Pharmaceuticals announces intention to move from Nasdaq OMX global market
Brief: Parnell Pharmaceuticals sees FY 2016 revenue of $14 million to $16 million
Brief: Parnell Pharmaceuticals says manufacturing deal with Merial
Brief: Parnell Pharmaceuticals announces pricing of underwritten public offering
Brief: Parnell Pharmaceuticals Q1 revenue rose 43 percent to $2.2 mln